Obstetrics & Gynecology news.

A Nature Medicine commentary argues that embryo editing and selection require joint governance as base-editing research advances and reproductive genomics commercialization expands. The authors emphasize that recent embryo experiments do not establish a clinical indication for heritable genome editing.

A commentary in Diabetes Care calls for automated insulin delivery systems tailored to pregnancy in women with type 1 diabetes. The authors highlight limitations of current U.S. systems and urge inclusion of pregnant participants in trials; the available abstract reports no new study results.

ASCO’s living guideline provides recommendations for recurrent high-grade serous or endometrioid ovarian, fallopian tube, and primary peritoneal cancer. A systematic review included 147 publications, with 36 directly informing recommendations; the supplied abstract notes that this version has been updated.